The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 28, 2022

Filed:

Nov. 07, 2018
Applicants:

Jichi Medical University, Tokyo, JP;

Tohoku University, Miyagi, JP;

Inventors:

Hitoshi Osaka, Tochigi, JP;

Takanori Yamagata, Tochigi, JP;

Eriko Jimbo, Tochigi, JP;

Akihiko Miyauchi, Tochigi, JP;

Takaaki Abe, Miyagi, JP;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/407 (2006.01); A61K 31/473 (2006.01); A61K 31/5513 (2006.01); A61P 25/28 (2006.01); A61P 25/00 (2006.01); A61P 43/00 (2006.01); A61K 31/5415 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5415 (2013.01); A61K 31/407 (2013.01); A61K 31/473 (2013.01); A61K 31/5513 (2013.01); A61P 25/00 (2018.01); A61P 25/28 (2018.01); A61P 43/00 (2018.01);
Abstract

A means for substantially improving mitochondrial dysfunction is provided. An aspect of the present invention relates to an agent for improving mitochondrial dysfunction, having a compound represented by the following formula, a stereoisomer or a salt thereof, or a solvate thereof, as an active ingredient. Another aspect of the present invention relates to a medicament or a pharmaceutical composition having the aforementioned compound, a stereoisomer or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, as an active ingredient, for use in preventing or treating a disease or symptom caused by mitochondrial dysfunction.


Find Patent Forward Citations

Loading…